This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Unspecified visual impairment (binocular)
H7_BLINDVISIMPNAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
649 |
4. Check minimum number of eventsNone |
649 |
5. Include endpointsNone |
649 |
6. Filter based on genotype QC (FinnGen only) |
584 |
Control definitions (FinnGen only)
- Control exclude
- H7_VISUALDISTBLIND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Unspecified visual impairment (binocular)
based on the number of shared cases.
Similar with more cases:
- Visual impairment including blindness (binocular or monocular)
- Visual disturbances and blindness
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 584 | 336 | 248 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | 60.00 | 58.68 | 61.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 616
- Matched controls
- 6160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H54.7
ICD-10 Finland
Unspecified visual loss
12771.6
307.7
594
9
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.0
134.7
209
334
H53.1
ICD-10 Finland
Subjective visual disturbances
16.3
107.2
96
69
XCK00
NOMESCO Finland
Perimetry
10.3
97.5
120
141
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.8
96.4
255
673
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.1
90.8
162
293
XCK10
NOMESCO Finland
Photography of fundus of eye
6.2
73.5
148
298
XCH00
NOMESCO Finland
Eye pressure measurement
8.8
70.3
96
127
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
7.0
59.3
100
167
XCD10
NOMESCO Finland
Electrophysiological examination of eye
11.3
47.0
51
49
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
82.8
41.5
46
6
H53.4
ICD-10 Finland
Visual field defects
97.0
41.4
45
5
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.6
40.7
168
577
H36.01
ICD-10 Finland
Diabetic maculopathy
14.0
39.4
37
28
H53.9
ICD-10 Finland
Visual disturbance, unspecified
9.3
38.0
47
54
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
74.8
37.4
42
6
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
5.4
32.7
69
141
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
5.2
32.7
72
153
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
7.1
31.9
50
76
Z3229
NOMESCO Finland
Other healthcare associate professional
4.0
31.4
102
294
H26.02
ICD-10 Finland
Presenil cataract
8.2
30.1
41
53
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
30.1
295
1597
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
29.6
29.2
39
14
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.6
28.3
269
1424
Z71.8
ICD-10 Finland
Other specified counselling
2.6
28.1
279
1506
A28
ICPC
Limited function/disability NOS
2.9
28.1
169
710
H53.0
ICD-10 Finland
Amblyopia ex anopsia
105.0
27.9
30
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.2
26.7
125
455
H52.0
ICD-10 Finland
Hypermetropia
7.7
26.6
38
52
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
4.4
26.5
72
181
H26.4
ICD-10 Finland
After-cataract
3.4
25.7
106
356
H47.2
ICD-10 Finland
Optic atrophy
260.1
24.9
25
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.9
24.6
39
60
H53.2
ICD-10 Finland
Diplopia
36.2
24.5
31
9
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.7
24.4
60
139
R51.80
ICD-10 Finland
Headache
2.9
24.4
143
588
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
23.8
86
265
H25.0
ICD-10 Finland
Senile incipient cataract
4.1
23.5
68
179
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.2
23.4
41
70
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
9.4
23.1
28
31
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.4
23.1
34
48
ZXE00
NOMESCO Finland
One hour or less
2.3
23.0
285
1661
N03AX14
ATC
levetiracetam; systemic
6.7
22.9
37
58
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
22.7
87
278
L28
ICPC
Limited function/disability (L)
2.6
22.6
161
729
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
22.5
304
1833
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.5
22.3
86
276
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
23.2
21.9
31
14
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
21.9
104
379
N03AG01
ATC
valproic acid; systemic, rectal
4.0
21.6
65
176
S01EC01
ATC
acetazolamide; systemic
6.3
21.5
37
62
R42
ICD-10 Finland
Dizziness and giddiness
2.5
21.2
182
898
Z2446
NOMESCO Finland
Social worker
3.5
20.9
80
255
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
20.0
87
300
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
20.0
258
1508
R4110
NOMESCO Finland
Physiotherapy
2.3
19.9
211
1137
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
19.6
78
255
H25.1
ICD-10 Finland
Senile nuclear cataract
2.3
19.4
218
1201
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
5.5
19.1
38
73
N03AF02
ATC
oxcarbazepine; oral
5.3
19.1
39
77
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
18.7
204
1107
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.5
18.2
30
48
Z3231
NOMESCO Finland
Registered nurse
2.2
18.2
212
1181
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
68.7
17.8
20
*
H3601, H547,
ICD-10 Finland
+∞
17.8
17
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
17.7
219
1247
H57.1
ICD-10 Finland
Ocular pain
4.3
17.1
45
110
Z2221
NOMESCO Finland
Medical doctor
2.2
16.9
197
1091
H3601, E116,
ICD-10 Finland
92.6
16.6
18
*
N05BA09
ATC
clobazam; oral
20.7
16.5
24
12
H52.2
ICD-10 Finland
Astigmatism
5.6
16.5
32
60
R4120
NOMESCO Finland
Occupational therapy
3.5
16.5
61
190
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
5.8
16.2
30
54
AA1AD
NOMESCO Finland
CT of head and brain
2.1
16.0
198
1120
S01EA05
ATC
brimonidine; ophthalmic
5.5
15.8
31
59
A10AE04
ATC
insulin glargine; parenteral
2.9
15.7
83
319
S01ED51
ATC
timolol, combinations; ophthalmic
3.1
15.7
71
250
P85
ICPC
Mental retardation
22.8
15.6
22
10
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
12.8
15.5
27
22
K99
ICPC
Cardiovascular disease other
5.5
15.3
30
57
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
15.3
47
129
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.3
15.2
31
61
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.1
15.2
43
111
S01ED01
ATC
timolol; ophthalmic
4.4
15.0
38
90
H54.3
ICD-10 Finland
Mild or no visual impairment, binocular
82.1
14.6
16
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
14.6
123
592
N03AX16
ATC
[U] pregabalin
2.2
14.6
157
837
F05
ICPC
Visual disturbance other
4.4
14.5
37
88
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
14.5
140
713
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.0
14.5
233
1439
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.6
14.3
88
365
WX199
NOMESCO Finland
Other local analgesia
4.5
14.0
35
82
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
24.4
13.9
19
8
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.3
13.8
119
577
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
13.6
245
1566
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
13.6
117
567
H54.0
ICD-10 Finland
Blindness, binocular
+∞
13.6
13
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
13.4
62
221
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.5
13.4
22
35
CKC12
NOMESCO Finland
Photocoagulation of retina
4.0
13.4
39
103
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
13.3
34
81
Z3226
NOMESCO Finland
Physiotherapist
2.2
13.3
141
744
H52.1
ICD-10 Finland
Myopia
3.9
13.3
40
108
N02AX02
ATC
tramadol; systemic, rectal
1.9
13.2
272
1812
N03AX09
ATC
lamotrigine; oral
3.7
13.2
43
123
G44.2
ICD-10 Finland
Tension-type headache
2.4
13.1
103
480
H3603, E103,
ICD-10 Finland
23.1
13.0
18
8
ZYC01
NOMESCO Finland
Remote contact by phone
3.0
12.6
58
206
Z2445
NOMESCO Finland
Psychologist
3.3
12.5
48
153
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.0
12.4
57
202
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
12.4
57
202
ZXD05
NOMESCO Finland
Urgent procedure
1.9
12.4
198
1208
S01EE01
ATC
latanoprost; ophthalmic
3.0
12.4
56
197
H53.8
ICD-10 Finland
Other visual disturbances
14.7
12.3
20
14
N03AX18
ATC
lacosamide; systemic
18.5
12.1
18
10
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
18.5
12.1
18
10
ZXA00
NOMESCO Finland
Right side
2.0
12.1
180
1071
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.8
12.1
38
106
N05CD08
ATC
midazolam; nasal, systemic
4.6
12.0
29
66
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
15.0
11.9
19
13
T89
ICPC
Diabetes insulin dependent
3.5
11.9
41
122
J01FF01
ATC
clindamycin; systemic
2.0
11.8
174
1031
XCD20
NOMESCO Finland
Photoangiography of eye
5.7
11.7
22
40
N05BA04
ATC
oxazepam; oral
1.9
11.6
175
1043
TAB00
NOMESCO Finland
Lumbar puncture
3.4
11.6
42
129
114
Kela drug reimbursment
Glaucoma
2.6
11.5
70
288
F29
ICPC
Eye symptom/complaint other
2.4
11.5
88
404
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
11.4
107
535
SPAT1229
SPAT
Assessment of need for aid
2.8
11.3
59
225
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.2
172
1030
A10AB05
ATC
insulin aspart; parenteral
2.7
11.2
64
255
L17
ICPC
Foot/toe symptom/complaint
1.9
11.2
210
1344
N02BF02
ATC
pregabalin; oral
3.0
11.1
52
186
ZXD35
NOMESCO Finland
Usual procedure
4.1
11.1
31
79
K29
ICPC
Cardiovascular sympt/complt other
3.7
11.0
36
103
C08CA13
ATC
lercanidipine; oral
2.2
10.9
103
516
R5140
NOMESCO Finland
Monitoring the use of the aid
2.4
10.8
82
374
CKD40
NOMESCO Finland
Endophotocoagulation of retina
8.2
10.7
23
29
WX002
NOMESCO Finland
Sedation and analgesia
2.0
10.7
130
718
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.5
10.6
26
60
N05AH04
ATC
quetiapine; oral
2.0
10.5
124
677
ZXA05
NOMESCO Finland
Left side
1.9
10.5
157
931
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
5.6
10.5
20
37
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.5
10.4
36
107
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
16.4
10.4
16
10
DFF00
NOMESCO Finland
Pure tone audiometry
2.3
10.4
83
388
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.1
10.3
45
155
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
10.3
144
834
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.8
10.3
31
84
N06AX21
ATC
duloxetine; oral
2.3
10.2
83
391
R52.9
ICD-10 Finland
Pain, unspecified
2.4
10.2
75
338
ZXA10
NOMESCO Finland
Bilateral
2.0
10.0
131
740
N06AX26
ATC
vortioxetine; oral
2.7
10.0
55
215
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.2
10.0
41
136
H3603, E106,
ICD-10 Finland
40.8
10.0
12
*
RT274, ,
NOMESCO Finland
40.8
10.0
12
*
H02AB06
ATC
prednisolone; systemic
1.7
9.9
292
2113
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.9
181
1142
N06AX16
ATC
venlafaxine; oral
2.2
9.7
94
475
R5110, ,
SPAT
2.4
9.7
67
293
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
55.9
9.7
11
*
S29
ICPC
Skin symptom/complaint other
1.9
9.6
140
819
N05CD07
ATC
temazepam; oral
2.2
9.6
84
407
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
9.6
47
173
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
9.5
210
1397
R02
ICPC
Shortness of breath/dyspnoea
2.1
9.5
98
507
H54.4
ICD-10 Finland
Blindness, monocular
101.5
9.4
10
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
101.5
9.4
10
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
101.5
9.4
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
9.4
88
438
N03AX12
ATC
[U] gabapentin; oral
2.1
9.4
105
560
UJD02
NOMESCO Finland
Gastroscopy
3.1
9.4
40
136
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.3
230
1577
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.5
9.3
21
29
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.3
213
1432
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.2
290
2123
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
13.9
9.2
15
11
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
9.2
70
320
R06.0
ICD-10 Finland
Dyspnoea
1.8
9.2
181
1164
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
9.1
70
322
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
9.1
86
431
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
9.0
64
283
RT490, ,
NOMESCO Finland
37.3
9.0
11
*
Z00.8
ICD-10 Finland
Other general examinations
2.4
9.0
63
277
B01AF02
ATC
apixaban; oral
2.1
9.0
90
461
R60.0
ICD-10 Finland
Localized oedema
2.1
8.9
89
455
A10AC01
ATC
insulin (human); parenteral
2.4
8.9
60
260
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
8.9
156
968
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
8.8
435
3570
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.8
178
1152
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.3
8.8
33
104
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
8.7
54
224
H50.1
ICD-10 Finland
Divergent concomitant strabismus
14.3
8.7
14
10
WX140
NOMESCO Finland
Parabulbar anesthesy
2.9
8.7
40
142
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
8.7
56
237
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
8.7
112
628
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
8.7
55
231
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
8.7
113
636
UKC02
NOMESCO Finland
Cystoscopy
2.0
8.7
99
532
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.7
8.6
20
44
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.7
8.6
20
44
U07
ICPC
Urine symptom/complaint other
2.3
8.6
66
302
WX402
NOMESCO Finland
General anaesthesia
1.8
8.6
141
854
S18
ICPC
Laceration/cut
1.7
8.6
289
2139
EB1AA, ,
SPAT
2.6
8.6
49
195
H46
ICD-10 Finland
Optic neuritis
10.2
8.6
16
16
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
8.5
46
178
M79.6
ICD-10 Finland
Pain in limb
1.7
8.5
267
1940
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.6
8.5
49
196
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.6
8.5
28
81
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
91.3
8.4
9
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
91.3
8.4
9
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
8.4
78
388
N06AX11
ATC
mirtazapine; oral
1.7
8.3
209
1433
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.7
8.3
46
181
ZY010
NOMESCO Finland
Hospital outpatient
2.7
8.2
46
182
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
8.2
40
147
H50.0
ICD-10 Finland
Convergent concomitant strabismus
11.9
8.1
14
12
H40.0
ICD-10 Finland
Glaucoma suspect
2.4
8.1
56
245
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
8.1
180
1192
H36.00
ICD-10 Finland
Diabetic background retinopathy
6.4
8.1
20
32
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.5
8.0
27
79
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
8.0
319
2451
C07AB07
ATC
bisoprolol; oral
1.6
8.0
291
2187
SPAT1301
SPAT
No procedures
1.7
8.0
195
1324
N06AB05
ATC
paroxetine; oral
2.9
8.0
38
138
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
13.2
7.9
13
10
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.6
7.8
16
19
R13
ICD-10 Finland
Dysphagia
2.4
7.8
54
236
H20.1
ICD-10 Finland
Chronic iridocyclitis
9.6
7.8
15
16
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
7.8
108
619
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.8
120
713
PA6AD
NOMESCO Finland
CT of neck arteries
3.4
7.7
27
81
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
15.3
7.7
12
8
CKD15
NOMESCO Finland
Injection of vitreous substitute
15.3
7.7
12
8
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
45.6
7.7
9
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
7.7
250
1821
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.8
7.7
23
62
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.1
7.7
21
53
N05BA01
ATC
diazepam; systemic, rectal
2.0
7.7
88
473
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
18.6
7.6
11
6
N06AB04
ATC
citalopram; systemic
1.8
7.6
129
788
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.6
170
1124
Z49.0
ICD-10 Finland
Preparatory care for dialysis
12.0
7.6
13
11
N03AG04
ATC
vigabatrin; oral
25.4
7.6
10
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.2
7.6
20
49
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
3.9
7.6
22
58
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.0
7.6
15
17
RT150, ,
NOMESCO Finland
10.2
7.6
14
14
N05AA02
ATC
levomepromazine; systemic
3.2
7.5
30
98
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.0
7.5
88
476
SPAT1262
SPAT
Handing over of treatment supplies
1.9
7.5
106
611
C03CA01
ATC
furosemide; systemic
1.7
7.5
191
1308
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.4
7.5
27
83
A10AB04
ATC
insulin lispro; parenteral
3.4
7.5
27
83
WX892
NOMESCO Finland
Monitored bed care
2.4
7.5
53
235
A10AE05
ATC
insulin detemir; parenteral
2.6
7.3
44
180
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.6
7.3
43
174
F83
ICD-10 Finland
Mixed specific developmental disorders
7.0
7.3
17
25
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
7.3
119
717
H3601, E103,
ICD-10 Finland
11.0
7.3
13
12
RS221, ,
NOMESCO Finland
4.2
7.3
19
46
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.3
122
741
A11CC03
ATC
alfacalcidol; systemic
3.9
7.3
21
55
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.4
7.3
18
29
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
7.3
92
511
R52.2
ICD-10 Finland
Other chronic pain
3.0
7.3
32
111
C08CA01
ATC
amlodipine; oral
1.6
7.2
224
1607
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.0
7.2
31
106
L04AA06
ATC
mycophenolic acid; systemic
4.6
7.2
17
38
Z01.2
ICD-10 Finland
Dental examination
1.6
7.2
286
2177
K90
ICPC
Stroke/cerebrovascular accident
3.5
7.2
24
70
181
Kela drug reimbursment
Retigabine and vigabatrin
30.4
7.2
9
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
7.2
40
158
M02AA10
ATC
ketoprofen; topical
1.9
7.2
94
529
N02BE01
ATC
paracetamol; systemic, rectal
1.9
7.1
527
4672
A23
ICPC
Risk factor NOS
2.1
7.1
72
369
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.3
7.1
55
254
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.0
111
662
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.8
7.0
124
765
A02BC02
ATC
pantoprazole; systemic
1.6
7.0
389
3191
A10AE06
ATC
insulin degludec; parenteral
3.1
7.0
29
97
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.9
124
768
EBA00
NOMESCO Finland
Extraction of tooth
1.6
6.9
228
1657
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.5
6.9
23
67
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.8
6.9
35
132
183
Kela drug reimbursment
Lamotrigin and topiramate
8.4
6.9
14
17
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.2
6.9
18
44
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
6.8
348
2792
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
6.8
84
462
M54.5
ICD-10 Finland
Low back pain
1.6
6.8
205
1456
WZC30
NOMESCO Finland
Teaching
1.8
6.8
102
599
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
6.8
44
187
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.8
81
441
H13
ICPC
Plugged feeling ear
1.8
6.8
122
757
U13
ICPC
Bladder symptom/complaint other
3.5
6.8
23
68
H40.9
ICD-10 Finland
Glaucoma, unspecified
4.0
6.8
19
49
R51
ICD-10 Finland
Headache
2.6
6.7
40
163
R53
ICD-10 Finland
Malaise and fatigue
1.7
6.7
164
1105
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
22.8
6.7
9
*
UDC00
NOMESCO Finland
Ear microscopy
2.2
6.7
55
260
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
6.6
126
793
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
6.6
44
189
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.3
6.6
25
79
R55
ICD-10 Finland
Syncope and collapse
2.0
6.6
76
408
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
12.4
6.6
11
9
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
4.2
6.6
17
41
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
8.8
6.6
13
15
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.1
6.6
27
90
A04
ICPC
Weakness/tiredness general
1.8
6.6
103
613
A99
ICPC
Disease/condition unspecnature/site
2.0
6.5
73
388
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
6.5
61
304
A11
ICPC
Chest pain NOS
2.1
6.5
61
304
Z31.5
ICD-10 Finland
Genetic counselling
2.5
6.5
40
166
D50.8
ICD-10 Finland
Other iron deficiency anaemias
5.8
6.5
17
30
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
6.5
97
569
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.0
6.5
18
46
H3603, E116,
ICD-10 Finland
70.6
6.4
7
*
J01AA02
ATC
doxycycline; systemic
1.6
6.4
436
3710
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
14.5
6.4
10
7
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
14.5
6.4
10
7
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
6.4
147
974
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
6.4
126
801
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
6.4
250
1882
R06AE07
ATC
cetirizine; oral
1.6
6.4
246
1846
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.8
6.4
31
114
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
8.3
6.4
13
16
WW500
NOMESCO Finland
Blood transfusion
2.8
6.3
32
120
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
9.4
6.3
12
13
B01AC04
ATC
clopidogrel; oral
1.8
6.3
99
590
H3601, E106,
ICD-10 Finland
+∞
6.3
6
*
H3601, H350,
ICD-10 Finland
+∞
6.3
6
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.1
6.3
56
274
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.1
6.2
18
36
S21
ICPC
Skin texture symptom/complaint
1.8
6.2
97
577
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.2
6.2
50
235
N03AE01
ATC
clonazepam; systemic
2.6
6.1
36
146
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.4
6.1
40
171
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.1
48
223
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.9
6.1
28
100
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
6.1
74
406
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.4
6.0
40
172
R4110, ,
SPAT
1.9
6.0
81
459
A10AB01
ATC
insulin (human); parenteral
2.9
6.0
27
95
A10AA02, ,
ATC
2.9
6.0
27
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
215
1023
2.69
28.14
6.3
3.9
933.13
369.08
ng/l
0.33
167
801
439
3064
2.51
23.49
8.0
5.5
6.94
6.62
mmol/l
2.02
424
2890
70
193
3.96
22.71
2.7
2.0
—
—
—
0
0
297
1784
2.28
22.08
5.9
3.3
14.99
88.05
e6/l
1.27
236
1363
232
1263
2.34
21.70
3.0
2.4
—
—
—
0
0
109
413
2.99
21.41
3.7
3.0
275.81
217.04
ng/l
0.52
100
380
321
2031
2.21
20.55
7.0
4.0
54.55
115.41
e6/l
1.40
237
1422
389
2689
2.21
19.54
12.4
7.8
1.21
1.22
mmol/l
0.47
352
2337
262
1559
2.18
19.23
2.8
2.1
191.56
295.97
u/l
0.83
255
1480
219
1221
2.23
18.84
4.6
2.6
4.66
6.20
e6/l
1.06
200
1117
62
180
3.72
18.62
2.8
1.8
—
—
—
0
0
102
401
2.85
18.61
2.5
2.3
5.28
6.65
ug/l
0.41
91
356
338
2295
2.05
16.75
6.9
4.9
35.43
35.71
g/l
0.38
316
2155
334
2280
2.02
16.06
2.6
2.1
92.32
95.70
pmol/l
0.73
182
1176
249
1538
2.04
15.81
5.7
3.3
0.15
0.47
e6/l
4.40
190
1121
110
487
2.53
15.74
8.6
10.2
1.20
1.31
mmol/l
0.84
105
479
184
1019
2.15
15.61
3.0
2.8
2.47
2.46
mmol/l
0.65
165
908
109
487
2.50
15.27
2.9
2.4
30.12
31.77
u/l
0.15
89
397
218
1305
2.04
14.91
5.3
4.3
91.16
89.50
%
0.42
211
1282
125
602
2.35
14.82
7.4
4.9
1.53
1.89
mmol/l
0.65
113
498
101
468
2.39
12.97
11.1
5.4
5.05
5.11
kpa
0.34
96
449
482
3894
2.09
12.85
9.7
7.9
88.92
81.90
u/l
1.35
458
3673
143
774
2.10
12.56
8.7
6.3
1.08
1.09
mmol/l
0.11
133
712
225
1433
1.90
12.39
3.3
2.4
2.51
2.88
mg/l
1.77
196
1240
157
885
2.04
12.34
5.0
3.2
3.38
2.01
e6/l
0.51
71
433
155
878
2.02
11.98
2.9
4.1
0.81
0.82
mmol/l
0.47
148
836
23
44
5.39
11.62
1.1
1.1
—
—
—
0
0
43
134
3.37
11.58
1.3
1.6
424.93
471.55
mg/l
0.46
43
128
159
920
1.98
11.52
3.6
2.6
12.22
13.04
umol/l
0.69
151
857
150
853
2.00
11.41
3.4
2.6
2.26
2.32
g/l
0.72
142
790
162
948
1.96
11.34
5.0
3.0
0.90
0.97
e6/l
0.13
78
497
88
408
2.35
11.22
12.0
5.7
1.33
1.77
mmol/l
0.57
60
296
39
117
3.49
11.14
1.3
1.6
3.27
5.00
e6/l
0.45
26
90
579
5139
3.11
11.08
31.4
18.7
139.34
139.65
mmol/l
2.20
574
5030
39
118
3.46
11.00
1.4
1.7
255.78
1108.82
e6/l
0.43
27
95
22
43
5.27
10.86
1.1
1.1
—
—
—
0
0
326
2396
1.77
10.76
16.4
13.3
1.27
1.24
inr
0.31
279
2015
360
2723
1.77
10.75
6.2
6.7
12.86
12.44
umol/l
0.16
348
2590
578
5144
3.00
10.63
31.9
18.9
3.96
3.97
mmol/l
0.34
569
5021
322
2366
1.76
10.57
3.3
2.6
72.47
76.55
nmol/l
1.92
297
2137
98
490
2.19
10.42
9.9
7.5
10.01
9.34
mmol/l
0.38
93
467
573
5087
2.81
10.39
26.7
15.6
24.26
24.32
mg/l
0.02
485
4134
105
541
2.13
10.35
3.0
1.9
360.59
388.65
nmol/l
0.67
98
509
393
3071
1.77
10.27
9.8
9.8
4.18
4.06
e9/l
0.41
337
2668
154
913
1.92
10.25
2.4
1.9
—
—
—
0
0
541
4698
2.24
10.04
6.3
5.3
1.92
1.94
mu/l
0.09
513
4333
460
3785
1.85
9.89
5.7
4.4
14.12
12.00
mm/h
2.15
431
3518
138
800
1.93
9.78
3.6
2.6
21.22
22.76
%
0.61
131
749
19
39
5.00
8.89
1.1
1.1
—
—
—
0
0
584
5323
2.87
8.38
31.6
20.2
79.79
76.29
umol/l
1.01
578
5257
144
886
1.82
8.36
1.7
1.8
931.49
1169.69
nmol/l
2.59
111
681
532
4681
2.00
8.12
27.6
15.2
80.87
80.79
ml/min/173m2
0.02
499
4282
316
2422
1.63
8.01
11.1
7.6
1.21
1.22
mmol/l
0.38
293
2235
54
238
2.39
7.69
1.5
2.2
1.40
1.50
g/l
0.30
46
219
223
1581
1.64
7.65
3.6
3.5
1868.14
1357.82
ng/l
0.57
195
1356
251
1834
1.62
7.62
3.0
3.3
2.37
2.36
mmol/l
0.79
230
1657
495
4287
1.79
7.53
32.7
20.1
331.13
332.28
g/l
1.92
495
4263
467
3981
1.72
7.49
5.0
4.2
14.48
14.79
pmol/l
1.93
436
3632
103
589
1.90
7.48
8.7
10.2
12.64
11.97
kpa
0.64
98
569
37
141
2.73
7.10
3.6
3.2
2.24
2.31
index
0.03
25
81
406
3375
1.60
6.83
3.9
3.3
60.93
47.16
u/l
1.59
385
3181
102
601
1.84
6.72
2.9
4.5
303.58
248.61
u/l
0.46
95
579
593
5526
2.96
6.64
37.7
23.8
249.25
250.83
e9/l
0.22
580
5401
99
581
1.84
6.60
8.9
10.3
0.42
1.14
mmol/l
0.76
81
492
320
2532
1.55
6.60
4.1
3.2
126.49
116.26
ug/l
0.27
307
2366
593
5528
2.95
6.59
37.7
23.8
4.41
4.48
e12/l
2.36
579
5388
593
5528
2.95
6.59
38.9
24.4
39.62
40.18
%
1.93
588
5463
593
5531
2.93
6.53
38.1
24.1
131.78
134.40
g/l
3.96
588
5467
212
1533
1.58
6.49
1.9
1.7
20.50
20.56
nmol/l
0.02
195
1299
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
142
2.63
6.48
2.5
3.9
0.40
0.32
iu/ml
0.26
15
84
304
2385
1.54
6.47
3.2
2.8
—
—
estimate
—
0
0
573
5268
2.26
6.43
16.0
11.7
27.68
25.41
u/l
0.88
557
5113
47
214
2.30
6.24
1.9
2.3
45.26
39.11
u/l
0.80
42
189
17
32
5.43
6.19
1.1
1.0
—
—
—
0
0
76
420
1.92
6.09
4.5
4.4
122.95
80.01
ng/l
2.05
70
366
239
1805
1.53
5.91
5.3
3.5
6.90
7.55
mmol/l
1.29
216
1527
514
4598
1.71
5.77
8.6
6.3
40.78
39.24
mmol/mol
2.25
486
4322
526
4737
1.76
5.74
5.5
5.0
6.16
5.93
mmol/l
1.85
486
4355
101
624
1.74
5.65
2.1
3.2
9.29
8.85
umol/l
0.04
86
540
178
1275
1.56
5.53
3.4
2.9
353.32
345.88
umol/l
0.36
158
1128
14
25
5.70
5.40
1.1
1.2
—
—
—
0
0
28
107
2.69
5.38
2.0
2.6
181.67
61.15
ug/min
0.91
18
61
9
8
11.39
5.30
1.1
1.4
1.22
1.18
mmol/l
—
9
8
54
279
2.03
5.25
11.2
14.3
15.77
15.71
%
0.05
54
269
16
35
4.66
5.21
1.1
1.5
106.31
72.11
umol/l
1.98
16
35
34
149
2.36
4.96
1.5
1.3
—
—
—
0
0
66
377
1.84
4.79
3.0
2.7
76.32
64.23
ml/min/173m2
2.01
34
151
171
1259
1.50
4.56
1.4
1.6
2.39
2.24
g/l
0.47
102
729
211
1635
1.44
4.29
3.6
2.5
55.17
62.69
u/l
0.90
203
1528
26
109
2.45
4.20
1.8
1.3
—
—
—
0
0
26
109
2.45
4.20
1.8
1.3
—
—
—
0
0
159
1172
1.48
4.18
1.9
1.9
1.05
1.25
mg/l
0.54
122
916
52
288
1.88
4.17
2.3
3.4
4.30
4.49
pmol/l
0.77
44
254
13
30
4.40
4.14
1.6
2.1
—
—
—
0
0
13
30
4.40
4.14
1.6
2.1
—
—
—
0
0
13
30
4.40
4.14
1.6
2.1
—
—
—
0
0
12
27
4.51
3.95
4.5
1.7
145.67
100.96
ng/l
0.60
12
27
56
324
1.80
3.93
2.4
1.7
—
—
—
0
0
221
1753
1.41
3.87
3.4
3.2
30.33
32.92
u/l
0.82
209
1664
18
66
2.78
3.78
1.1
1.2
—
—
—
0
0
377
3285
1.38
3.66
3.6
3.2
—
—
—
0
0
526
4870
1.55
3.61
6.5
5.7
2.51
2.69
mmol/l
4.72
496
4519
12
30
4.06
3.61
1.7
2.1
—
—
—
0
0
12
31
3.93
3.50
1.5
1.1
0.71
0.54
ratio
—
7
21
99
686
1.53
3.47
2.3
1.8
—
—
—
0
0
12
32
3.80
3.40
2.6
2.3
1.59
1.55
umol/l
0.09
12
27
207
1663
1.37
3.25
6.3
4.1
13.50
9.21
mg/mmol
0.53
148
1029
73
480
1.59
3.22
10.9
10.4
118.23
121.06
g/l
0.60
73
470
60
376
1.66
3.20
1.9
1.6
—
—
—
0
0
10
24
4.22
3.20
1.4
1.5
—
—
—
0
0
19
79
2.45
3.16
1.2
1.4
—
—
—
0
0
31
159
2.00
3.15
1.4
1.4
266.70
297.09
ug/g
0.33
20
93
11
30
3.71
3.10
1.1
1.1
—
—
—
0
0
22
99
2.27
3.09
1.2
1.2
—
—
—
0
0
517
4807
1.47
3.09
5.7
5.0
4.40
4.60
mmol/l
4.46
484
4485
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
176
1394
1.37
2.99
1.4
1.4
2.88
1.52
u/ml
0.64
42
346
25
121
2.11
2.96
1.4
1.6
215.92
271.94
u/ml
0.35
12
54
319
2767
1.32
2.89
5.1
3.9
0.00
0.00
estimate
0.50
64
585
32
174
1.89
2.78
1.9
1.5
0.20
0.09
iu/ml
—
8
36
26
133
2.00
2.69
2.3
2.0
0.00
0.00
g/l
-0.00
26
125
25
127
2.01
2.64
1.3
1.5
—
—
—
0
0
320
2802
1.30
2.60
5.1
3.9
0.00
5.87
estimate
0.80
66
597
6
180
0.33
2.58
2.5
1.8
0.61
2.76
mg/l
—
6
135
11
36
3.09
2.57
4.4
2.9
0.45
0.78
index
0.98
11
36
90
651
1.45
2.56
2.4
1.9
—
—
—
0
0
47
294
1.65
2.56
3.1
4.3
0.51
0.61
%
2.14
47
294
12
44
2.76
2.56
2.4
2.8
567.67
904.23
mg
0.62
12
44
511
4783
1.40
2.55
5.7
4.9
1.41
1.47
mmol/l
2.42
475
4432
322
2827
1.29
2.55
5.1
3.9
0.07
0.54
estimate
0.42
59
558
100
741
1.42
2.50
2.4
2.3
126.98
120.89
ug/g
0.09
84
589
22
109
2.06
2.49
1.5
1.6
114.17
124.70
au/ml
—
6
38
24
123
1.99
2.48
1.7
1.8
6.47
5.62
iu/l
—
5
46
490
4562
1.36
2.47
4.9
4.2
1.35
1.27
mmol/l
1.39
447
4193
8
21
3.84
2.47
2.4
6.6
—
—
—
0
0
20
383
0.51
2.40
1.7
1.7
3.69
3.49
mmol/l
0.38
15
290
47
300
1.61
2.38
3.1
4.3
1.31
1.20
%
0.37
47
300
81
585
1.44
2.34
2.0
1.8
1.65
1.52
%
0.53
68
512
16
72
2.25
2.29
1.2
1.5
—
—
—
0
0
16
73
2.22
2.22
1.2
1.5
—
—
—
0
0
16
73
2.22
2.22
1.2
1.5
—
—
—
0
0
31
508
0.59
2.20
1.7
2.0
3.40
3.50
ratio
0.27
26
408
29
166
1.78
2.19
2.1
1.7
9.70
8.64
u/l
0.14
19
125
138
1107
1.32
2.10
4.7
4.5
22.17
21.60
%
0.12
58
521
11
43
2.59
2.09
1.5
1.2
125.73
101.47
pmol/l
1.31
11
43
20
104
1.95
2.02
2.6
3.2
0.66
0.85
nmol/l
0.87
12
83
50
340
1.51
1.97
3.3
4.3
123.80
128.98
g/l
0.94
50
333
46
308
1.53
1.94
1.1
1.1
—
—
—
0
0
43
285
1.55
1.90
1.6
1.4
—
—
—
0
0
8
28
2.88
1.86
1.5
3.0
—
—
—
0
0
37
238
1.59
1.86
2.3
1.6
20.30
24.35
iu/l
0.31
27
197
12
53
2.29
1.81
1.7
1.8
—
—
—
0
0
12
53
2.29
1.81
1.7
1.8
—
—
—
0
0
12
53
2.29
1.81
1.7
1.8
—
—
—
0
0
35
226
1.58
1.74
1.3
1.7
0.40
0.34
mg/l
0.26
16
98
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
30
2.69
1.73
1.1
1.1
—
—
—
0
0
107
855
1.30
1.68
1.3
1.3
2.48
11.38
u/ml
3.61
37
325
165
1398
1.25
1.61
5.2
5.3
2.29
2.53
ug/l
0.16
155
1251
30
191
1.60
1.60
1.7
1.6
44.02
10.46
u/ml
—
5
39
6
20
3.02
1.58
1.3
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
26
2.71
1.58
2.0
2.2
113.79
129.46
%
—
7
26
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
27
170
1.62
1.51
1.2
1.2
—
—
—
0
0
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
35
238
1.50
1.43
2.9
6.3
1.48
1.53
%
0.10
35
226
6
23
2.62
1.37
5.0
2.7
30.67
35.57
umol/l
—
6
14
28
183
1.56
1.37
1.6
1.5
0.22
0.23
g/l
0.13
28
174
56
421
1.36
1.35
5.6
4.1
1.23
1.23
mmol/l
0.28
49
363
28
186
1.53
1.28
1.3
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
18
2.79
1.28
1.0
1.1
110.80
102.83
%
—
5
18
25
162
1.57
1.28
2.7
3.4
1.97
3.47
ratio
0.92
19
91
28
188
1.51
1.23
1.6
1.5
1.13
1.15
g/l
0.18
28
177
5
19
2.64
1.22
1.6
1.2
91.20
72.00
%
—
5
19
0
34
0.00
1.16
0.0
1.2
—
180.60
—
0
34
7
32
2.20
1.08
2.0
2.8
459.57
781.75
u/ml
—
7
32
24
161
1.51
1.08
1.3
1.1
4.10
4.10
—
5
20
111
945
1.21
1.04
1.4
1.3
35.75
31.60
iu/ml
0.15
31
296
12
68
1.78
1.01
1.2
1.5
—
—
—
0
0
5
23
2.18
0.98
2.0
2.3
—
—
—
0
0
7
36
1.96
0.97
1.1
1.3
—
—
—
0
0
12
69
1.75
0.97
1.2
1.5
—
—
—
0
0
12
69
1.75
0.97
1.1
1.5
—
—
—
0
0
9
50
1.81
0.97
3.8
1.7
—
—
—
0
0
0
31
0.00
0.96
0.0
1.1
—
9.19
—
0
31
30
217
1.40
0.95
1.9
1.7
6.16
5.29
iu/ml
—
7
52
7
37
1.90
0.94
1.1
1.3
—
—
—
0
0
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
24
167
1.45
0.93
1.5
3.0
—
—
—
0
0
23
160
1.45
0.90
1.3
1.2
—
—
—
0
0
52
414
1.28
0.90
1.5
1.5
—
—
—
0
0
123
1076
1.18
0.87
1.7
1.7
429.83
440.56
pmol/l
0.12
106
900
46
363
1.29
0.85
1.2
1.2
154.57
150.31
u/ml
0.02
16
149
8
45
1.79
0.84
1.0
1.2
—
—
—
0
0
139
1556
0.86
0.81
5.4
3.9
0.00
0.01
estimate
0.96
57
540
8
47
1.71
0.81
1.0
1.2
—
—
—
0
0
8
48
1.68
0.79
1.0
1.1
—
—
—
0
0
8
48
1.68
0.79
1.0
1.1
—
—
—
0
0
16
107
1.51
0.77
9.6
3.2
11.84
9.62
pmol/l
0.33
16
107
64
534
1.22
0.76
2.6
4.2
4.66
20.68
ug/l
1.08
47
448
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
23
167
1.39
0.74
1.4
1.3
—
—
—
0
0
9
55
1.65
0.73
1.0
1.1
—
—
—
0
0
22
159
1.40
0.73
1.3
1.2
—
—
—
0
0
17
117
1.47
0.72
1.5
1.4
—
—
—
0
0
13
84
1.56
0.72
1.2
1.6
—
—
—
0
0
5
26
1.93
0.70
4.2
2.3
0.06
0.11
nmol/l
—
5
19
15
101
1.50
0.70
3.0
10.7
103.67
104.63
mmol/l
0.31
15
92
11
69
1.61
0.68
1.8
1.5
—
—
—
0
0
5
27
1.86
0.68
2.6
4.3
102.20
179.26
nmol/l
—
5
27
52
623
0.82
0.68
4.8
4.7
32.57
31.62
%
0.23
37
404
225
2094
1.12
0.65
2.1
1.9
1.47
1.33
mmol/l
0.96
197
1778
5
29
1.73
0.64
2.0
1.2
5.28
4.01
umol/l
—
5
24
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
21
275
0.76
0.58
3.0
2.9
14.46
76.35
u/ml
2.46
21
266
8
54
1.49
0.57
2.1
3.6
3.76
6.56
nmol/l
—
8
54
6
36
1.67
0.57
5.3
14.3
645.83
916.17
nmol/l
—
6
36
20
150
1.34
0.56
1.5
2.0
—
—
—
0
0
60
516
1.18
0.55
4.0
3.6
—
—
—
0
0
21
160
1.32
0.54
1.4
1.7
—
—
—
0
0
11
158
0.69
0.53
1.8
1.8
73.09
41.10
nmol/l
0.33
11
150
9
64
1.41
0.51
1.1
1.2
—
—
—
0
0
47
545
0.85
0.46
7.2
7.1
—
—
—
0
0
16
121
1.33
0.44
1.3
1.2
—
1.06
—
0
7
10
69
1.46
0.44
1.4
1.3
—
—
—
0
0
17
131
1.31
0.42
1.5
1.2
—
—
—
0
0
8
58
1.38
0.41
2.9
4.3
—
—
—
0
0
46
401
1.16
0.39
2.6
2.3
12.05
12.76
nmol/l
0.16
39
365
13
169
0.76
0.37
1.1
1.1
0.85
0.89
g/l
0.33
13
169
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
10
72
1.40
0.37
1.1
1.2
3.60
1.42
u/ml
—
5
26
201
2113
0.93
0.37
4.9
3.7
0.00
0.04
estimate
2.35
57
498
6
45
1.34
0.34
1.0
1.0
—
—
—
0
0
15
118
1.28
0.33
1.1
1.6
—
—
—
0
0
67
735
0.90
0.32
1.4
1.5
—
—
—
0
0
13
164
0.79
0.31
1.1
1.1
1.60
1.54
g/l
0.19
13
164
8
106
0.75
0.29
1.3
1.9
—
—
—
0
0
118
1249
0.93
0.26
4.8
3.8
1.02
1.02
kg/l
2.14
84
830
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.6
—
322.00
—
0
5
16
134
1.20
0.23
1.4
1.4
—
—
—
0
0
5
39
1.28
0.23
1.2
2.5
—
—
—
0
0
5
39
1.28
0.23
1.2
2.5
—
—
—
0
0
5
40
1.25
0.22
1.4
3.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
30.91
—
0
8
86
816
1.06
0.18
3.7
3.2
0.65
0.81
ug/l
1.44
59
514
11
131
0.84
0.17
1.5
1.3
—
—
—
0
0
112
1074
1.05
0.17
2.0
1.7
—
—
—
0
0
14
162
0.86
0.16
1.2
1.8
—
—
—
0
0
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
19
168
1.14
0.16
1.5
1.3
263.67
250.04
miu/ml
—
9
85
61
645
0.94
0.15
2.7
2.2
—
—
—
0
0
18
160
1.13
0.14
1.1
1.3
—
—
—
0
0
151
1549
0.97
0.12
4.5
3.3
0.00
0.07
estimate
0.66
54
472
12
136
0.88
0.11
1.3
1.5
—
—
—
0
0
5
47
1.06
0.09
1.4
3.3
186.20
198.49
e6/l
—
5
35
30
282
1.07
0.09
1.5
1.3
—
—
—
0
0
6
56
1.07
0.08
1.2
1.4
—
—
—
0
0
5
63
0.79
0.08
1.4
2.1
—
—
—
0
0
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
30
317
0.94
0.08
3.5
8.2
24.85
24.75
mmol/l
0.04
30
303
12
133
0.90
0.07
1.1
1.5
—
—
—
0
0
29
303
0.95
0.05
2.7
1.9
—
—
—
0
0
16
171
0.93
0.05
2.6
4.2
1.08
1.32
mmol/l
1.10
16
166
58
594
0.97
0.04
2.5
2.1
—
—
—
0
0
14
148
0.94
0.02
1.2
1.1
—
11.19
—
0
19
36
354
1.02
0.00
2.8
2.0
—
—
—
0
0
15
145
1.04
0.00
3.0
1.5
—
—
—
0
0
14
144
0.97
0.00
1.0
1.4
—
—
—
0
0
11
113
0.97
0.00
1.1
1.5
—
—
—
0
0
193
1925
1.00
0.00
5.0
3.9
27.04
37.77
ng/l
1.49
138
1389
7
78
0.90
-0.00
1.3
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
7.6
—
—
—
0
0
10
100
1.00
-0.00
1.3
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
9.9
—
10.19
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
78.43
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
8
85
0.94
-0.00
1.8
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
6.44
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
2.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.5
—
57.75
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
11
110
1.00
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
72
0.97
-0.00
1.3
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: H7_BLINDVISIMPNAS – Unspecified visual impairment (binocular)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).